US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lexeo Therapeutics

5.72

+0.22004.00%

Pre-market: 5.720.00000.00%06:53 EDT

Volume:719.35K

Turnover:4.16M

Market Cap:417.49M

PE:-2.29

High:5.96

Open:5.67

Low:5.67

Close:5.50

52wk High:10.99

52wk Low:1.45

Shares:72.99M

Float Shares:45.01M

Volume Ratio:0.73

T/O Rate:1.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5000

EPS(LYR):-3.0934

ROE:-80.69%

ROA:-44.66%

PB:3.46

PE(LYR):-1.85

Loading ...

Overview Company News Filings

Lexeo Therapeutics selloff looks ‘highly unwarranted,’ says H.C. Wainwright

Lexeo Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Press Release: Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters' Option to Purchase Additional Shares in the Public Offering

Lexeo Therapeutics Executives Make Major Stock Moves!

Lexeo Therapeutics Chief Development Officer Sandi See Tai Reports Sale of Common Shares

Lexeo Therapeutics CEO Richard Nolan Reports Disposal of Common Shares

Lexeo Therapeutics price target lowered to $18 from $20 at Leerink

Lexeo Therapeutics Shares up 2.5% After Co's Stock Sale, Private Placement

THOMSON REUTERS

Lexeo Therapeutics 15.625M share Spot Secondary priced at $8.00

Lexeo Therapeutics Shares Fall 5.9% Premarket After Co's Stock Sale, Private Placement

THOMSON REUTERS

Lexeo Therapeutics Inc Announces Public Offering And Private Placement For $135 Million

Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement

THOMSON REUTERS

Lexeo Therapeutics Inc - Offers 15,625,000 Shares at $8.00 per Share

THOMSON REUTERS

Lexeo Therapeutics Announces Public Offering and Concurrent Private Placement of Common Stock and Pre-Funded Warrants

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS

Lexeo Therapeutics Initiated at Buy by Guggenheim

Guggenheim Initiates Coverage on Lexeo Therapeutics With Buy Rating, $30 Price Target

MT Newswires Live

Chardan Raises Price Target on Lexeo Therapeutics to $17 From $15, Keeps Buy Rating

MT Newswires Live

Buy Rating for Lexeo Therapeutics Driven by Regulatory Progress and Promising Clinical Data on LX2006

Lexeo Therapeutics Is Maintained at Outperform by Leerink Partners

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LXEO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LXEO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXEO\",,,,,undefined,":{"symbol":"LXEO","market":"US","secType":"STK","nameCN":"Lexeo Therapeutics","latestPrice":5.72,"timestamp":1774468800000,"preClose":5.5,"halted":0,"volume":719353,"hourTrading":{"tag":"盘前","latestPrice":5.72,"preClose":5.72,"latestTime":"06:53 EDT","volume":408,"amount":2347.970028,"timestamp":1774522421307,"change":0,"changeRate":0,"amplitude":0.038462},"delay":0,"changeRate":0.03999999999999995,"floatShares":45005000,"shares":72987327,"eps":-2.5,"marketStatus":"Pre-Mkt","change":0.22,"latestTime":"03-26 07:39:44 EDT","open":5.67,"high":5.96,"low":5.67,"amount":4164665.661661,"amplitude":0.052727,"askPrice":6.18,"askSize":100,"bidPrice":5.17,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.5,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774531800000},"marketStatusCode":1,"adr":0,"listingDate":1698984000000,"exchange":"NASDAQ","adjPreClose":5.72,"preHourTrading":{"tag":"盘前","latestPrice":5.72,"preClose":5.72,"latestTime":"06:53 EDT","volume":408,"amount":2347.970028,"timestamp":1774522421307,"change":0,"changeRate":0,"amplitude":0.038462},"postHourTrading":{"tag":"盘后","latestPrice":5.72,"preClose":5.72,"latestTime":"16:10 EDT","volume":4067,"amount":23268.74,"timestamp":1774469405151,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7284559843717754,"impliedVol":0.4779,"impliedVolPercentile":0.104},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXEO\",,,,,undefined,":{"symbol":"LXEO","floatShares":45005000,"roa":"-44.66%","roe":"-80.69%","lyrEps":-3.093449,"volumeRatio":0.7284559843717754,"shares":72987327,"dividePrice":0,"high":5.96,"amplitude":0.052727,"preClose":5.5,"low":5.67,"week52Low":1.45,"pbRate":"3.46","week52High":10.99,"institutionHeld":0,"latestPrice":5.72,"eps":-2.5,"divideRate":0,"volume":719353,"delay":0,"ttmEps":-2.5,"open":5.67,"prevYearClose":9.93,"prevWeekClose":5.65,"prevMonthClose":7.18,"prevQuarterClose":9.93,"fiveDayClose":5.755,"twentyDayClose":6.89,"sixtyDayClose":10.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LXEO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-05","symbol":"LXEO","fiscalQuarterEnding":"2025/09","expectedEps":-0.48,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2025-08-14","symbol":"LXEO","fiscalQuarterEnding":"2025/06","expectedEps":-0.64,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2025-05-12","symbol":"LXEO","fiscalQuarterEnding":"2025/03","expectedEps":-0.8,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.99}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LXEO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LXEO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1766030400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LXEO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LXEO","date":"2026-03-25","current":-2.288,"percent":0.57539,"low":-8.903248,"twenty":-6.203539,"median":-4.280746,"eighty":-2.11554,"high":-0.6043,"avg":-4.15095,"sd":2.062862,"marketCap":401430298},"quantilePoints":[{"date":"2023-11-03","current":-4.257819,"twenty":-4.257819,"median":-4.257819,"eighty":-4.257819,"marketCap":271355051},{"date":"2023-11-10","current":-4.199758,"twenty":-4.199758,"median":-4.091377,"eighty":-4.048799,"marketCap":267654754},{"date":"2023-11-17","current":-4.292656,"twenty":-4.257819,"median":-4.118472,"eighty":-4.064282,"marketCap":273575228},{"date":"2023-11-24","current":-4.373941,"twenty":-4.270979,"median":-4.199758,"eighty":-4.070475,"marketCap":278755643},{"date":"2023-12-01","current":-4.923587,"twenty":-4.377038,"median":-4.259754,"eighty":-4.081313,"marketCap":313785113},{"date":"2023-12-08","current":-5.031968,"twenty":-4.945263,"median":-4.26556,"eighty":-4.111505,"marketCap":320692333},{"date":"2023-12-15","current":-4.58828,"twenty":-4.855461,"median":-4.333298,"eighty":-4.161824,"marketCap":306423687},{"date":"2023-12-22","current":-5.849059,"twenty":-5.408075,"median":-4.389424,"eighty":-4.194339,"marketCap":390623587},{"date":"2023-12-29","current":-5.805172,"twenty":-5.505138,"median":-4.537237,"eighty":-4.207282,"marketCap":387692577},{"date":"2024-01-05","current":-5.857039,"twenty":-5.805172,"median":-4.621669,"eighty":-4.218567,"marketCap":391156497},{"date":"2024-01-12","current":-5.896937,"twenty":-5.857039,"median":-4.799136,"eighty":-4.257819,"marketCap":393821051},{"date":"2024-01-19","current":-6.012642,"twenty":-5.955803,"median":-4.957419,"eighty":-4.257819,"marketCap":401548257},{"date":"2024-01-26","current":-6.66298,"twenty":-6.148663,"median":-5.403559,"eighty":-4.260916,"marketCap":444980484},{"date":"2024-02-02","current":-6.706868,"twenty":-6.322251,"median":-5.468033,"eighty":-4.26169,"marketCap":447911493},{"date":"2024-02-09","current":-6.714848,"twenty":-6.590366,"median":-5.777243,"eighty":-4.264786,"marketCap":448444404},{"date":"2024-02-16","current":-6.072489,"twenty":-6.589568,"median":-5.827115,"eighty":-4.287237,"marketCap":405545088},{"date":"2024-02-23","current":-6.343796,"twenty":-6.544084,"median":-5.876988,"eighty":-4.341427,"marketCap":423664054},{"date":"2024-03-01","current":-5.8331,"twenty":-6.543286,"median":-5.916886,"eighty":-4.373941,"marketCap":389557765},{"date":"2024-03-08","current":-5.857039,"twenty":-6.520145,"median":-5.890953,"eighty":-4.383231,"marketCap":391156497},{"date":"2024-03-15","current":-6.292966,"twenty":-6.520145,"median":-5.916886,"eighty":-4.447485,"marketCap":417815207},{"date":"2024-03-22","current":-6.028084,"twenty":-6.505782,"median":-5.977118,"eighty":-4.547445,"marketCap":400228597},{"date":"2024-03-28","current":-6.128418,"twenty":-6.497802,"median":-5.937219,"eighty":-4.601636,"marketCap":406890192},{"date":"2024-04-05","current":-5.265543,"twenty":-6.474661,"median":-5.932845,"eighty":-4.625869,"marketCap":349600479},{"date":"2024-04-12","current":-5.241463,"twenty":-6.410602,"median":-5.90231,"eighty":-4.683238,"marketCap":348001696},{"date":"2024-04-19","current":-4.844139,"twenty":-6.359022,"median":-5.876988,"eighty":-4.791277,"marketCap":321621782},{"date":"2024-04-26","current":-4.88026,"twenty":-6.350977,"median":-5.858281,"eighty":-4.83704,"marketCap":324019956},{"date":"2024-05-03","current":-6.182772,"twenty":-6.32828,"median":-5.876988,"eighty":-4.840714,"marketCap":410498948},{"date":"2024-05-10","current":-6.881509,"twenty":-6.410602,"median":-5.90231,"eighty":-4.84735,"marketCap":477707444},{"date":"2024-05-17","current":-6.653707,"twenty":-6.497802,"median":-5.932845,"eighty":-4.860193,"marketCap":461893680},{"date":"2024-05-24","current":-7.346604,"twenty":-6.546981,"median":-6.018356,"eighty":-4.875444,"marketCap":509993878},{"date":"2024-05-31","current":-7.617118,"twenty":-6.584345,"median":-6.028342,"eighty":-4.885879,"marketCap":528772723},{"date":"2024-06-07","current":-8.28154,"twenty":-6.629029,"median":-6.03658,"eighty":-4.908353,"marketCap":574896200},{"date":"2024-06-14","current":-8.903248,"twenty":-6.66298,"median":-6.072489,"eighty":-4.908353,"marketCap":618054597},{"date":"2024-06-21","current":-7.441521,"twenty":-6.711656,"median":-6.103378,"eighty":-4.917985,"marketCap":516582946},{"date":"2024-06-28","current":-7.05236,"twenty":-6.714848,"median":-6.103378,"eighty":-4.921032,"marketCap":489567767},{"date":"2024-07-05","current":-7.066597,"twenty":-6.782675,"median":-6.120366,"eighty":-4.923587,"marketCap":490556127},{"date":"2024-07-12","current":-8.276794,"twenty":-6.842522,"median":-6.15029,"eighty":-4.991251,"marketCap":574566747},{"date":"2024-07-15","current":-8.352728,"twenty":-6.873712,"median":-6.156275,"eighty":-4.995541,"marketCap":579838001},{"date":"2024-08-02","current":-6.198104,"twenty":-6.865914,"median":-6.161186,"eighty":-4.999831,"marketCap":430266153},{"date":"2024-08-09","current":-5.54792,"twenty":-6.840926,"median":-6.144305,"eighty":-5.014306,"marketCap":385131036},{"date":"2024-08-16","current":-5.180835,"twenty":-6.826318,"median":-6.112265,"eighty":-5.010821,"marketCap":400038148},{"date":"2024-08-23","current":-5.215088,"twenty":-6.797868,"median":-6.103378,"eighty":-5.014306,"marketCap":402683028},{"date":"2024-08-30","current":-4.975314,"twenty":-6.782675,"median":-6.066504,"eighty":-4.996865,"marketCap":384168866},{"date":"2024-09-06","current":-4.881117,"twenty":-6.774695,"median":-6.03259,"eighty":-4.924513,"marketCap":376895445},{"date":"2024-09-13","current":-4.22602,"twenty":-6.738787,"median":-6.028084,"eighty":-4.89684,"marketCap":326312109},{"date":"2024-09-20","current":-4.461512,"twenty":-6.721232,"median":-5.996218,"eighty":-4.873838,"marketCap":344495661},{"date":"2024-09-27","current":-3.814978,"twenty":-6.714848,"median":-5.932845,"eighty":-4.83926,"marketCap":294573545},{"date":"2024-10-04","current":-3.900612,"twenty":-6.71405,"median":-5.90231,"eighty":-4.736975,"marketCap":301185746},{"date":"2024-10-11","current":-3.408218,"twenty":-6.71006,"median":-5.876988,"eighty":-4.623769,"marketCap":263165591},{"date":"2024-10-18","current":-3.89633,"twenty":-6.698313,"median":-5.858281,"eighty":-4.466448,"marketCap":300855136},{"date":"2024-10-25","current":-4.238865,"twenty":-6.663872,"median":-5.849059,"eighty":-4.397847,"marketCap":327303939},{"date":"2024-10-31","current":-3.543091,"twenty":-6.66298,"median":-5.819389,"eighty":-4.373941,"marketCap":273579808},{"date":"2024-11-08","current":-3.378247,"twenty":-6.65417,"median":-5.783228,"eighty":-4.26556,"marketCap":260851321},{"date":"2024-11-15","current":-2.970727,"twenty":-6.653707,"median":-5.678921,"eighty":-4.257819,"marketCap":257253067},{"date":"2024-11-22","current":-2.367417,"twenty":-6.629978,"median":-5.544882,"eighty":-4.208893,"marketCap":205008871},{"date":"2024-11-29","current":-3.142556,"twenty":-6.626181,"median":-5.512207,"eighty":-4.166207,"marketCap":272132743},{"date":"2024-12-06","current":-2.703438,"twenty":-6.607553,"median":-5.450079,"eighty":-4.100138,"marketCap":234106904},{"date":"2024-12-13","current":-2.72253,"twenty":-6.599941,"median":-5.414849,"eighty":-4.066934,"marketCap":235760202},{"date":"2024-12-20","current":-2.306323,"twenty":-6.589568,"median":-5.281597,"eighty":-3.914314,"marketCap":199718319},{"date":"2024-12-27","current":-2.588885,"twenty":-6.578686,"median":-5.241463,"eighty":-3.893837,"marketCap":224187120},{"date":"2025-01-03","current":-2.546883,"twenty":-6.570706,"median":-5.215088,"eighty":-3.826967,"marketCap":220549866},{"date":"2025-01-10","current":-2.604159,"twenty":-6.564766,"median":-5.210806,"eighty":-3.754178,"marketCap":225509758},{"date":"2025-01-17","current":-1.981757,"twenty":-6.550955,"median":-5.17013,"eighty":-3.659982,"marketCap":171612264},{"date":"2025-01-24","current":-2.142882,"twenty":-6.53506,"median":-5.110187,"eighty":-3.528106,"marketCap":185565027},{"date":"2025-01-31","current":-2.005371,"twenty":-6.527327,"median":-5.031968,"eighty":-3.425345,"marketCap":173657111},{"date":"2025-02-07","current":-2.070307,"twenty":-6.515357,"median":-5.011134,"eighty":-3.395373,"marketCap":179280293},{"date":"2025-02-14","current":-1.611936,"twenty":-6.499398,"median":-4.991251,"eighty":-3.192195,"marketCap":139587239},{"date":"2025-02-21","current":-1.539361,"twenty":-6.496206,"median":-4.928215,"eighty":-3.10819,"marketCap":133302506},{"date":"2025-02-28","current":-1.142107,"twenty":-6.453914,"median":-4.914373,"eighty":-2.892068,"marketCap":98901859},{"date":"2025-03-07","current":-1.073351,"twenty":-6.437026,"median":-4.893962,"eighty":-2.779043,"marketCap":92947901},{"date":"2025-03-14","current":-1.134467,"twenty":-6.376035,"median":-4.880688,"eighty":-2.703438,"marketCap":98240308},{"date":"2025-03-21","current":-1.027514,"twenty":-6.356851,"median":-4.852166,"eighty":-2.601104,"marketCap":88978596},{"date":"2025-03-28","current":-1.387527,"twenty":-6.34619,"median":-4.840506,"eighty":-2.545356,"marketCap":136439657},{"date":"2025-04-04","current":-0.891258,"twenty":-6.338037,"median":-4.795483,"eighty":-2.464405,"marketCap":87640072},{"date":"2025-04-11","current":-0.732587,"twenty":-6.311324,"median":-4.74555,"eighty":-2.42393,"marketCap":72037483},{"date":"2025-04-17","current":-0.769723,"twenty":-6.30019,"median":-4.649906,"eighty":-2.355198,"marketCap":75689153},{"date":"2025-04-25","current":-1.238984,"twenty":-6.294572,"median":-4.621669,"eighty":-2.271508,"marketCap":121832978},{"date":"2025-05-02","current":-1.590085,"twenty":-6.292966,"median":-4.546304,"eighty":-2.190247,"marketCap":156357855},{"date":"2025-05-09","current":-1.012793,"twenty":-6.292343,"median":-4.461512,"eighty":-2.110502,"marketCap":99590991},{"date":"2025-05-16","current":-0.81978,"twenty":-6.289736,"median":-4.386933,"eighty":-1.999259,"marketCap":89607702},{"date":"2025-05-23","current":-0.935157,"twenty":-6.278497,"median":-4.373941,"eighty":-1.883139,"marketCap":102219157},{"date":"2025-05-30","current":-0.871396,"twenty":-6.262715,"median":-4.292656,"eighty":-1.737224,"marketCap":95249669},{"date":"2025-06-06","current":-0.992845,"twenty":-6.24372,"median":-4.263625,"eighty":-1.61652,"marketCap":108524884},{"date":"2025-06-13","current":-2.052375,"twenty":-6.232879,"median":-4.257819,"eighty":-1.598825,"marketCap":224338921},{"date":"2025-06-20","current":-2.127645,"twenty":-6.223303,"median":-4.238865,"eighty":-1.614228,"marketCap":232566510},{"date":"2025-06-27","current":-2.06491,"twenty":-6.203846,"median":-4.21373,"eighty":-1.629508,"marketCap":225709077},{"date":"2025-07-03","current":-2.198289,"twenty":-6.20262,"median":-4.195762,"eighty":-1.653954,"marketCap":240288372},{"date":"2025-07-11","current":-2.267449,"twenty":-6.200163,"median":-4.140386,"eighty":-1.70361,"marketCap":247848006},{"date":"2025-07-18","current":-2.104429,"twenty":-6.198104,"median":-4.103992,"eighty":-1.718889,"marketCap":230028868},{"date":"2025-07-25","current":-1.812971,"twenty":-6.182772,"median":-4.083635,"eighty":-1.764727,"marketCap":198170410},{"date":"2025-08-01","current":-2.336608,"twenty":-6.17781,"median":-4.06594,"eighty":-1.812971,"marketCap":255407640},{"date":"2025-08-08","current":-2.198289,"twenty":-6.166096,"median":-4.041907,"eighty":-1.86404,"marketCap":240288372},{"date":"2025-08-15","current":-2.26542,"twenty":-6.156275,"median":-3.900612,"eighty":-1.87168,"marketCap":258647483},{"date":"2025-08-22","current":-2.26069,"twenty":-6.144305,"median":-3.890098,"eighty":-1.890778,"marketCap":258107509},{"date":"2025-08-29","current":-2.251231,"twenty":-6.128418,"median":-3.827824,"eighty":-1.92165,"marketCap":257027562},{"date":"2025-09-05","current":-2.35055,"twenty":-6.121976,"median":-3.799992,"eighty":-1.925602,"marketCap":268367013},{"date":"2025-09-12","current":-2.449869,"twenty":-6.107404,"median":-3.74219,"eighty":-1.93461,"marketCap":279706464},{"date":"2025-09-19","current":-2.582295,"twenty":-6.103535,"median":-3.677964,"eighty":-1.952307,"marketCap":294825733},{"date":"2025-09-26","current":-3.07416,"twenty":-6.103378,"median":-3.543091,"eighty":-1.960886,"marketCap":350983015},{"date":"2025-10-03","current":-3.16875,"twenty":-6.084882,"median":-3.508838,"eighty":-1.966064,"marketCap":361782492},{"date":"2025-10-10","current":-3.878171,"twenty":-6.074043,"median":-3.510979,"eighty":-1.967068,"marketCap":442778573},{"date":"2025-10-17","current":-4.147751,"twenty":-6.062913,"median":-3.59126,"eighty":-1.975097,"marketCap":473557083},{"date":"2025-10-24","current":-4.256529,"twenty":-6.041368,"median":-3.707936,"eighty":-1.980826,"marketCap":485976483},{"date":"2025-10-31","current":-5.750439,"twenty":-6.046619,"median":-3.744331,"eighty":-1.985047,"marketCap":656539109},{"date":"2025-11-07","current":-5.854784,"twenty":-6.046619,"median":-3.79777,"eighty":-1.986886,"marketCap":614553293},{"date":"2025-11-14","current":-6.25113,"twenty":-6.074043,"median":-3.827824,"eighty":-1.989502,"marketCap":656156069},{"date":"2025-11-21","current":-6.195502,"twenty":-6.104132,"median":-3.878171,"eighty":-2.002315,"marketCap":650317083},{"date":"2025-11-28","current":-6.856078,"twenty":-6.134773,"median":-3.890098,"eighty":-2.017382,"marketCap":719655044},{"date":"2025-12-05","current":-6.320664,"twenty":-6.150597,"median":-3.89885,"eighty":-2.031318,"marketCap":663454802},{"date":"2025-12-12","current":-6.814357,"twenty":-6.187864,"median":-3.917739,"eighty":-2.03527,"marketCap":715275804},{"date":"2025-12-19","current":-6.925612,"twenty":-6.202522,"median":-4.030982,"eighty":-2.038234,"marketCap":726953776},{"date":"2025-12-26","current":-7.342817,"twenty":-6.232879,"median":-4.056541,"eighty":-2.044162,"marketCap":770746173},{"date":"2026-01-02","current":-6.904752,"twenty":-6.267809,"median":-4.06981,"eighty":-2.050547,"marketCap":724764157},{"date":"2026-01-09","current":-6.584894,"twenty":-6.292758,"median":-4.093288,"eighty":-2.054882,"marketCap":691189986},{"date":"2026-01-16","current":-5.215069,"twenty":-6.292758,"median":-4.112303,"eighty":-2.065989,"marketCap":547404952},{"date":"2026-01-23","current":-5.340231,"twenty":-6.291928,"median":-4.144069,"eighty":-2.070307,"marketCap":560542671},{"date":"2026-01-30","current":-5.263743,"twenty":-6.288275,"median":-4.176128,"eighty":-2.074127,"marketCap":552514065},{"date":"2026-02-06","current":-4.79091,"twenty":-6.285897,"median":-4.204325,"eighty":-2.07973,"marketCap":502882683},{"date":"2026-02-13","current":-4.568401,"twenty":-6.271979,"median":-4.22602,"eighty":-2.08467,"marketCap":479526738},{"date":"2026-02-20","current":-4.359798,"twenty":-6.2553,"median":-4.256529,"eighty":-2.093982,"marketCap":457630540},{"date":"2026-02-27","current":-4.797864,"twenty":-6.249281,"median":-4.259754,"eighty":-2.101306,"marketCap":503612556},{"date":"2026-03-06","current":-4.700516,"twenty":-6.238621,"median":-4.26556,"eighty":-2.104054,"marketCap":493394330},{"date":"2026-03-13","current":-4.610121,"twenty":-6.229687,"median":-4.302155,"eighty":-2.104429,"marketCap":483905978},{"date":"2026-03-20","current":-4.026033,"twenty":-6.20894,"median":-4.311653,"eighty":-2.110959,"marketCap":422596623},{"date":"2026-03-25","current":-3.824384,"twenty":-6.203539,"median":-4.280746,"eighty":-2.11554,"marketCap":401430298}],"updateTime":1774520286262},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LXEO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2580624599","title":"Lexeo Therapeutics selloff looks ‘highly unwarranted,’ says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2580624599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580624599?lang=en_us&edition=fundamental","pubTime":"2025-11-04 01:05","pubTimestamp":1762189513,"startTime":"0","endTime":"0","summary":"H.C. Wainwright reiterated a Buy rating and $13 price target on Lexeo Therapeutics (LXEO), saying Monday’s selloff looks “highly unwarranted” given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-selloff-looks-highly-unwarranted-says-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-selloff-looks-highly-unwarranted-says-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2577824472","title":"Lexeo Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2577824472","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577824472?lang=en_us&edition=fundamental","pubTime":"2025-10-21 19:21","pubTimestamp":1761045660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXEO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 21, 2025 07:21 ET (11:21 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO"],"gpt_icon":0},{"id":"2577898016","title":"Press Release: Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters' Option to Purchase Additional Shares in the Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2577898016","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577898016?lang=en_us&edition=fundamental","pubTime":"2025-10-21 04:05","pubTimestamp":1760990700,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct. 20, 2025  -- Lexeo Therapeutics, Inc.  , a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced the closing of its previously announced underwritten public offering and concurrent private placement, for total gross proceeds to Lexeo of approximately $153.8 million, before deducting underwriting discounts and commission and other expenses payable by Lexeo in connection with the transaction and including the full exercise of the underwriters' option to purchase additional shares.Leerink Partners, Cantor, Stifel and Oppenheimer & Co. acted as joint book-running managers for the public offering. Baird acted as lead manager for the public offering. Leerink Partners served as sole Placement Agent in connection with the concurrent private placement.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","FA","BK4139","BK4130","BK4535","BK4539"],"gpt_icon":0},{"id":"2576993650","title":"Lexeo Therapeutics Executives Make Major Stock Moves!","url":"https://stock-news.laohu8.com/highlight/detail?id=2576993650","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576993650?lang=en_us&edition=fundamental","pubTime":"2025-10-18 10:02","pubTimestamp":1760752926,"startTime":"0","endTime":"0","summary":"New insider activity at Lexeo Therapeutics, Inc. ( ($LXEO) ) has taken place on October 17, 2025. In a series of significant stock transactions at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/lexeo-therapeutics-executives-make-major-stock-moves-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/lexeo-therapeutics-executives-make-major-stock-moves-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2576038060","title":"Lexeo Therapeutics Chief Development Officer Sandi See Tai Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2576038060","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576038060?lang=en_us&edition=fundamental","pubTime":"2025-10-18 07:30","pubTimestamp":1760743812,"startTime":"0","endTime":"0","summary":"Sandi See Tai, Chief Development Officer of Lexeo Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL9YFwsP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2576060755","title":"Lexeo Therapeutics CEO Richard Nolan Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2576060755","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576060755?lang=en_us&edition=fundamental","pubTime":"2025-10-18 07:26","pubTimestamp":1760743604,"startTime":"0","endTime":"0","summary":"Richard Nolan Townsend, Chief Executive Officer and Director of Lexeo Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL7ZTS8r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2576688560","title":"Lexeo Therapeutics price target lowered to $18 from $20 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2576688560","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576688560?lang=en_us&edition=fundamental","pubTime":"2025-10-18 01:15","pubTimestamp":1760721312,"startTime":"0","endTime":"0","summary":"Leerink analyst Mani Foroohar lowered the firm’s price target on Lexeo Therapeutics (LXEO) to $18 from $20 and keeps an Outperform rating on the sh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-price-target-lowered-to-18-from-20-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-price-target-lowered-to-18-from-20-at-leerink-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO"],"gpt_icon":0},{"id":"2576055315","title":"Lexeo Therapeutics Shares up 2.5% After Co's Stock Sale, Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2576055315","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576055315?lang=en_us&edition=fundamental","pubTime":"2025-10-17 21:39","pubTimestamp":1760708345,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nFWN3VY1R4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2576035015","title":"Lexeo Therapeutics 15.625M share Spot Secondary priced at $8.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2576035015","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576035015?lang=en_us&edition=fundamental","pubTime":"2025-10-17 18:20","pubTimestamp":1760696447,"startTime":"0","endTime":"0","summary":"Leerink, Cantor Fitzgerald, Stifel, Oppenheimer and Baird acted as joint book running managers for the offering. Published first on TheFly – the ul...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-15-625m-share-spot-secondary-priced-at-8-00-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-15-625m-share-spot-secondary-priced-at-8-00-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2576353030","title":"Lexeo Therapeutics Shares Fall 5.9% Premarket After Co's Stock Sale, Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2576353030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576353030?lang=en_us&edition=fundamental","pubTime":"2025-10-17 18:08","pubTimestamp":1760695702,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nFWN3VY23B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2576500704","title":"Lexeo Therapeutics Inc Announces Public Offering And Private Placement For $135 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2576500704","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576500704?lang=en_us&edition=fundamental","pubTime":"2025-10-17 11:44","pubTimestamp":1760672640,"startTime":"0","endTime":"0","summary":"Oct 16 (Reuters) - Lexeo Therapeutics Inc ::*LEXEO THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT*LEXEO THERAPEUTICS INC - ANNOUNCES PUBLIC OFFERING AND PRIVATE PLA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nRSD2KG0c0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2576738701","title":"Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2576738701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576738701?lang=en_us&edition=fundamental","pubTime":"2025-10-17 11:29","pubTimestamp":1760671794,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nTUA8VRQCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2576701035","title":"Lexeo Therapeutics Inc - Offers 15,625,000 Shares at $8.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2576701035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576701035?lang=en_us&edition=fundamental","pubTime":"2025-10-17 11:29","pubTimestamp":1760671794,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nTUA8VRQCN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2576577342","title":"Lexeo Therapeutics Announces Public Offering and Concurrent Private Placement of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2576577342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576577342?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:32","pubTimestamp":1760646765,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics Inc. has announced the commencement of an underwritten public offering of its common stock and pre-funded warrants, alongside a concurrent private placement to Balyasny Asset Management. In the private placement, Lexeo will sell shares of common stock and, in lieu of common stock, pre-funded warrants to purchase common stock. The completion of the public offering is not contingent on the private placement, and both transactions are subject to market and other customary conditions. All shares and pre-funded warrants to be sold in the offering will be issued by Lexeo. The company also intends to grant underwriters a 30-day option to purchase additional shares of common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL9ljnrd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B64PRP62.GBP","LU0314104364.USD","LU2095319765.USD","LU2210149790.SGD","BK4588","LXEO","IE00B3QW5Z07.USD","NDAQ","IE00BKPKM429.USD","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2576733077","title":"Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2576733077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576733077?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:19","pubTimestamp":1760645949,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nFWN3VX2NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2575736385","title":"Lexeo Therapeutics Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2575736385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575736385?lang=en_us&edition=fundamental","pubTime":"2025-10-15 22:36","pubTimestamp":1760538960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXEO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 15, 2025 10:36 ET (14:36 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2575896017","title":"Guggenheim Initiates Coverage on Lexeo Therapeutics With Buy Rating, $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2575896017","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575896017?lang=en_us&edition=fundamental","pubTime":"2025-10-15 19:37","pubTimestamp":1760528241,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics (LXEO) has an average rating of Buy and mean price target of $20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LXEO"],"gpt_icon":0},{"id":"2573928687","title":"Chardan Raises Price Target on Lexeo Therapeutics to $17 From $15, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2573928687","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573928687?lang=en_us&edition=fundamental","pubTime":"2025-10-08 19:58","pubTimestamp":1759924706,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics (LXEO) has an average rating of buy and mean price target of $18.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LXEO"],"gpt_icon":0},{"id":"2573479909","title":"Buy Rating for Lexeo Therapeutics Driven by Regulatory Progress and Promising Clinical Data on LX2006","url":"https://stock-news.laohu8.com/highlight/detail?id=2573479909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573479909?lang=en_us&edition=fundamental","pubTime":"2025-10-08 18:55","pubTimestamp":1759920936,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Tessa Romero has maintained their bullish stance on LXEO stock, giving a Buy rating yesterday. Tessa Romero’s rating is based o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-lexeo-therapeutics-driven-by-regulatory-progress-and-promising-clinical-data-on-lx2006-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-lexeo-therapeutics-driven-by-regulatory-progress-and-promising-clinical-data-on-lx2006-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","LXEO"],"gpt_icon":0},{"id":"2573696199","title":"Lexeo Therapeutics Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2573696199","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573696199?lang=en_us&edition=fundamental","pubTime":"2025-10-07 23:29","pubTimestamp":1759850940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXEO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 07, 2025 11:29 ET (15:29 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":70,"code":"91000000","status":"200"}]}}